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Hypovitaminosis D is common in Asian Indians. Physicians often prescribe 1500mg (60 000 IU) cholecalciferol per week for 8 weeks for vitamin D
deficiency in India. Its efficacy to increase serum 25-hydroxy vitamin D (25(OH)D) over short (2 months) and long (1 year) term is not known.
We supplemented a group of twenty-eight apparently healthy Asian Indians detected to have low serum 25(OH)D (mean 13·5 (SD 3·0) nmol/l) on
screening during January–March 2005. Serum parathyroid hormone (PTH) level was supranormal in 30% of them. Oral supplementation included
1500mg cholecalciferol per week and 1g elemental Ca daily for 8 weeks. Serum 25(OH)D, total Ca, inorganic P and intact (i) PTH were reassessed
in twenty-three subjects (twelve females and eleven males) who had follow up at both 8 weeks and 1 year. At 8 weeks the mean 25(OH)D levels
increased to 82·4 (SD 20·7) nmol/l and serum PTH normalized in all. Twenty-two of the twenty-three subjects had 25(OH)D levels . 49·9 nmol/l.
At 1 year, though the mean 25(OH)D level of 24·7 (SD 10·9) nmol/l was significantly higher than the baseline, all subjects were 25(OH)D deficient.
Five subjects with supranormal iPTH at baseline showed recurrence of biochemical hyperparathyroidism. Thus, with 8 weeks of cholecalciferol
supplementation in Asian Indians with chronic hypovitaminosis D, mean serum 25(OH)D levels would be normalized and serum PTH value would
be reduced to half. However, such quick supplementation would not maintain their 25(OH)D levels in the sufficient range for 1 year. For sustained
improvement in 25(OH)D levels vitamin D supplementation has to be ongoing after the initial cholecalciferol loading.
Hypovitaminosis: Vitamin D supplementation: Asian Indians: Serum 25-hydroxy vitamin D: Cholecalciferol
Hypovitaminosis D is common in India despite its sunny
environment(1–3). More than 90% of apparently healthy
Indians residing in India have subnormal serum 25-hydroxy
vitamin D (25(OH)D) levels with values almost undetectable
during winter(1–3). One fifth of them also have evidence of para-
thyroid hyperactivity reflected in serum parathyroid hormone
(PTH) levels(1,2). Poor exposure to sunshine and skin pigmenta-
tion are themain causes of their hypovitaminosis D(1). The usual
dress sense practised in India gives scope for sunshine exposure
to merely face and hands/forearm. Under these circumstances
the prospect of achieving normal serum 25(OH)D by sunshine
exposure seems a distant reality in urban Indians working
indoors. Recently Malabanan and colleagues reported success-
ful normalization of serum 25(OH)D levels at 8 weeks after
giving orally 1250mg (50 000 IU) cholecalciferol granules
each week to hypovitaminotic elderly Caucasians(4). Currently,
it is a common practice by physicians in India to prescribe a
cholecalciferol sachet of 1500mg to be taken each week for
1–8 weeks for overt or occult vitamin D deficiency. However,
its short- and long-term effects on serum 25(OH)D levels in
Asian Indians have not been systematically studied. Here, we
report on the efficacy of similar vitamin D supplementation
in Asian Indians as reported by Malabanan and co-workers, in
Caucasian subjects in terms of serum 25(OH)D and PTH
levels at 2 months and again after 1 year in the same group of
individuals(4).
Materials and methods
Subjects
Study subjects included twenty-eight apparently healthy Asian
Indians who were found to have subnormal serum 25(OH)D
levels on screening. Twenty-four of the twenty-eight subjects
were from a cohort of 193 first-degree relatives of patients
with nutritional osteomalacia or rickets who were investigated
at our centre for assessing association of the disease with
vitamin D receptor gene polymorphisms using a transmission
disequilibrium test. None of these relatives had clinical signs
and symptoms of overt metabolic bone disease such as bone
pains, myopathy or fractures. Besides, four of the twenty-
eight subjects were volunteers including three of the authors
(R. G., D. R. and N. T.). The criteria for selection of the
study subjects included: (1) age . 18 years; (2) residence in
Delhi; (3) commitment for follow-up at 2 months and again
after 1 year; (4) consent for 8 weeks of supplementation;
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(5) ability to recruit in the winter between January and March
2006. Blood samples were drawn at baseline for estimation of
serum total Ca, inorganic P, alkaline phosphatase, serum
25(OH)D and intact (i) PTH.
All study subjects were provided with packets containing
four sachets of cholecalciferol (each containing 1500mg
(60 000 IU) vitamin D3; Cadila Pharmaceutical, India) and
sixty tablets of CaCO3 (each tablet containing 500mg elemen-
tal Ca þ 6·5mg (250 IU) vitamin D3; Elder Pharmaceutical,
India). Subjects were counselled for daily intake of two tablets
of CaCO3 and weekly intake of a cholecalciferol sachet and
follow-up at completion of 4 weeks. Similar packets were
given after 4 weeks of follow-up. Drug compliance was
assessed by counting the empty sachets. Blood samples were
drawn at completion of 8 weeks of supplementation and
again after 1 year for biochemical assessment.
Daily dietary intake of proximate principles including Ca
and phytic acid was measured by semiquantitative FFQ and
24 h recall method using published data of nutritive value of
Indian foods(5,6).
None of the study subjects took Ca and vitamin D supple-
mentation after 2 months. The study protocol including
vitamin D-supplementation dose was approved by the
Institutional ethics committee and written informed consent
was obtained from all the subjects.
Follow up, compliance and actual number of subjects
analyzed
Three of the twenty-eight subjects did not follow up at 2
months for unknown reasons and two of the remaining
twenty-five subjects did not come for follow-up at 1 year
because of migration to other states. Two of the twenty-five
subjects who were followed up for 2 months admitted missing
Ca supplementation during the third and fourth weeks of sup-
plementation. These subjects gave their Ca tablets to their
female siblings who were earlier treated by us for nutritional
osteomalacia. However all the subjects confirmed weekly
intake of cholecalciferol and returned the correct number of
empty sachets to us on follow-up. None of the subjects com-
plained of side effects including gastrointestinal disturbance
after Ca intake either at 1 or 2 months of follow-up after the
start of supplementation. Final analysis was performed only
in twenty-three subjects (twelve females and eleven males),
who had follow-up at both 8-weeks and 1-year interval.
Biochemical estimations
Blood samples after an overnight fast without venostasis
were cold centrifuged at 800 g for 5min at 88C and serum
was stored in multiple aliquots at2208C. Serum total Ca, inor-
ganic P and alkaline phosphatase assays were assayed in
duplicate using commercial kits (Roche, Germany) and
semiautomated analyzer (Hitachi 4020; Boehringer, Germany).
Normal range and intra- and inter-assay CV for serum Ca was
2·0–2·6mmol/l, 3·6% and 3·8%; for P, 0·80–1·45mmol/l,
3·5% and 4·8%; and for alkaline phosphatase, , 840 IU/l up
to age 18 years and , 280 IU/l for . 18 years of age, 5·2%
and 4·1%, respectively. Serum iPTH was measured by an
immunoradiometric assay (Diasorin, Stillwater, MN, USA;
normal range 13–54 ng/l, intra- and inter-assay CV 4% and
8%, respectively). Serum 25(OH)D concentrations were
estimated by radioimmunoassay (Diasorin; normal range
22·4–93·8 nmol/l). Vitamin D deficiency, insufficiency and
sufficiency was defined based on serum 25(OH)D concen-
trations as , 49·9 nmol/l, 49·9–79·8 nmol/l, and . 79·8 nmol/l
respectively(7–9).
Statistical analysis
Data are shown as means and standard deviations. Analysis
was performed using SPSS software (version 10.0). ANOVA
followed by the Bonferroni correction test was used to com-
pare various indices at three different intervals. A value of
P,0·05 was considered significant.
Results
The mean daily dietary Ca intake of the study group was 650
(SD 409) mg. The mean age and BMI of female (33·9 (SD 13·1)
years and 22·1 (SD 3·0) kg/m2) and male (34 (SD 17) years
and 20·6 (SD 4·0) kg/m2) subjects were comparable (P¼0·95
and 0·33 respectively). Change in serum 25(OH)D values
in individual subjects and their mean values of biochemical
estimations performed at baseline, at 8 weeks and at 1 year
of follow-up after cholecalciferol and Ca supplementation
are shown in Fig. 1 and Table 1 respectively.
Baseline
At baseline, all study subjects were vitamin D-deficient and
serum PTH level was supranormal in 30% of them.
After 8 weeks of supplementation
After 8 weeks of supplementation, thirteen of twenty-three
subjects were vitamin D-sufficient with serum 25(OH)D
levels . 79·8 nmol/l, nine had serum 25(OH) in the insuffi-
cient range and only one subject remained vitamin D-deficient
(42·4 nmol/l, Fig. 1). None of the subjects had supranormal
iPTH.
Fig. 1. Change in serum 25-hydroxy vitamin D (25(OH)D) values in same
group of twenty- three subjects at 2 months and again after 1 year following
8 weeks of oral cholecalciferol (1500mg (60 000 IU)/week) and Ca sup-
plementation (1 g/d).
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At 1 year of follow up
At 1 year, serum 25(OH)D levels were in the deficient range in
all subjects. However, their mean 25(OH)D level was signifi-
cantly higher as compared to the baseline. There was no sig-
nificant difference in their mean PTH compared to baseline.
Interestingly, five of the seven patients who had high serum
iPTH at baseline again showed biochemical hyperparathyroid-
ism with serum PTH . 54 ng/l. Serum inorganic P values
were significantly lower at 1 year as compared to 2 months
after supplementation.
Discussion
The current study for the first time evaluates serum 25(OH)D
and PTH response at 2-months and again at 1-year interval
after 8 weeks of quick supplementation with oral cholecalci-
ferol in a group of apparently healthy Asian Indian subjects
who had been in the chronic hypovitaminotic state for years.
The results showed that after 8 weeks of oral supplementation
with 1500mg cholecalciferol per week, mean serum 25(OH)D
levels were in the range currently considered adequate or suf-
ficient for bone mineral homeostasis. The fact that the serum
25(OH)D level normalized in most study subjects also indi-
cates that impaired 25-hydroxylation is not involved in the
etiopathogenesis of subnormal 25(OH)D levels in Asian
Indians. The pattern of rise in serum 25(OH)D at 8 weeks
of supplementation with cholecalciferol and Ca supplemen-
tation and associated normalization of serum PTH levels
observed in the current study is akin to that observed earlier
in Caucasian subjects(4).
The recommended intake for vitamin Dwas 10mg (400 IU)/d
until 1997(10). Based on the belief that adequate vitaminD can be
obtained through exposure to sunshine, the Indian Council of
Medical Research made no recommendation for dietary vitamin
D in 1989(6). However, following increasing awareness about
wide prevalence of vitamin D deficiency in Asian Indians,
there has been debate in India regarding corrective measures
and adequate intake to correct hypovitaminosisD(11–13). Similar
debate is already on world-wide and there has been rethinking
on adequate dietary intake for vitamin D which would
maintain serum 25(OH)D in the vitamin D-sufficient range
of . 79·8 nmol/l(7–9). Recommended daily dietary intake for
vitamin D as suggested by various authors has varied from 25
to 250mg (1000 to 10 000 IU)(14,15).
In the current study, a dose of 1500mg cholecalciferol per
week in addition to 12·5mg (500 IU) provided daily
along with elemental Ca is equivalent to a dose of 216mg
(8642 IU)/d. The observations of the current study and that
of Malabanan et al. indicate that on an average, daily intake
of 200mg (8000 IU) vitamin D would bring serum 25(OH)D
levels to the vitamin D-sufficient range in most of the subjects
at 2 months(4). The daily oral dose of cholecalciferol which
would maintain serum 25(OH)D levels in the vitamin D-suffi-
cient range cannot be answered in the current study.
There has been no study to date for comparison of serum
25(OH)D and PTH response at 1 year after quick supplemen-
tation with oral 8-week cholecalciferol therapy. Serum
25(OH)D levels observed at baseline in the current study as
well as those reported in our previous study have indicated
that serum 25(OH)D levels are almost undetectable in Asian
Indians during winter(1). The results of the current study
indicate that with 8 weeks of cholecalciferol given at a dose
of 1500mg per week, serum 25(OH)D level increased twofold
in winter at 1 year. However, despite efficacy of such a quick
supplementation schedule, at 2 months normal 25(OH)D and
PTH homeostasis could not be maintained for a period of 1
year. This was indicated by the fact that (1) serum PTH
levels reverted to supranormal values at 1 year in those sub-
jects who had high serum PTH at baseline and (2) serum
25(OH)D levels could not be maintained in the vitamin D
insufficient to sufficient range.
There is a need for consensus to undertake corrective
measures for hypovitaminosis D in Asian Indians. The poten-
tial implications of 25(OH)D deficiency are wide ranging.
Specifically for Asian Indians it might involve association of
vitamin D deficiency with type 2 diabetes and pulmonary
tuberculosis(16,17). These two disorders have an unusually
high prevalence in Asian Indians(18,19).
The results of the current study indicate that cholecalciferol
given every week for 8 weeks in Asian Indians with chronic
hypovitaminosis D would correct their serum 25(OH)D
levels to the vitamin D-sufficient range and lower the serum
PTH value to half the existing levels at a short-term period
of 2 months. However, such quick supplementation would
not maintain their 25(OH)D levels in the sufficient range
Table 1. Change in serum Ca, 25-hydroxy vitamin D (25(OH)D) and intact PTH (iPTH) after cholecalciferol (1500mg (60 000 IU)/week) and Ca (1g/d)
supplementation*
(Mean values and standard deviations)
Baseline
(pre-supplementation)
After 8 weeks of supplementation
8 weeks 12 months
Parameters Mean SD Mean SD Mean SD
Serum total Ca (mmol/l) 2·27 0·22 2·22 0·17 2·34 0·17
Serum inorganic P (mg/dl) 1·32 0·13 1·42a 0·13 1·29b 0·13
Serum alkaline phosphatase (IU/l) 300 118 253 78 252 100
25(OH)D (nmol/l) 13·5a 3·0 82·4b 20·7 24·7c 10·9
Serum iPTH(ng/l) 54a 40 29b 20 72a 32
Supranormal PTH (n, %) 7 out of 23 (30·4 %) 0 out of 23 (nil) 14 out of 23 (60·1 %)
abc Values in the same row with different superscript are significantly different from each other.
* For details of subjects and procedures, see Materials and methods.
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for 1 year. For sustained improvement in 25(OH)D levels vita-
min D supplementation has to be ongoing after the 8 weeks of
vitamin D- loading schedule in Asian Indians. Whether it
should involve perennial fortification of common foods such
as milk with vitamin D or change in lifestyle including
exposure to sunshine needs to be investigated further.
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